These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36187087)

  • 1. Pharmacophore based virtual screening of cholinesterase inhibitors: search of new potential drug candidates as antialzheimer agents.
    Lakra N; Matore BW; Banjare P; Singh R; Singh J; Roy PP
    In Silico Pharmacol; 2022; 10(1):18. PubMed ID: 36187087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacophore-based drug design of AChE and BChE dual inhibitors as potential anti-Alzheimer's disease agents.
    Gao H; Jiang Y; Zhan J; Sun Y
    Bioorg Chem; 2021 Sep; 114():105149. PubMed ID: 34252860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of coumarin derivatives targeting acetylcholinesterase for Alzheimer's disease by field-based 3D-QSAR, pharmacophore model-based virtual screening, molecular docking, MM/GBSA, ADME and MD Simulation study.
    Saha B; Das A; Jangid K; Kumar A; Kumar V; Jaitak V
    Curr Res Struct Biol; 2024; 7():100124. PubMed ID: 38292820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacophore-based virtual screening and density functional theory approach to identifying novel butyrylcholinesterase inhibitors.
    Sakkiah S; Lee KW
    Acta Pharmacol Sin; 2012 Jul; 33(7):964-78. PubMed ID: 22684028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacophore mapping-based virtual screening followed by molecular docking studies in search of potential acetylcholinesterase inhibitors as anti-Alzheimer's agents.
    Ambure P; Kar S; Roy K
    Biosystems; 2014 Feb; 116():10-20. PubMed ID: 24325852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of novel cinnamic acid-tryptamine hybrid for inhibition of acetylcholinesterase and butyrylcholinesterase.
    Ghafary S; Ghobadian R; Mahdavi M; Nadri H; Moradi A; Akbarzadeh T; Najafi Z; Sharifzadeh M; Edraki N; Moghadam FH; Amini M
    Daru; 2020 Dec; 28(2):463-477. PubMed ID: 32372339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening of acetylcholinesterase inhibitors through pharmacophore-based 3D-QSAR modeling, ADMET, molecular docking, and MD simulation studies.
    Kumar H; Datusalia AK; Khatik GL
    In Silico Pharmacol; 2024; 12(1):13. PubMed ID: 38370859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacophore-based drug design for the identification of novel butyrylcholinesterase inhibitors against Alzheimer's disease.
    Jiang Y; Gao H
    Phytomedicine; 2019 Feb; 54():278-290. PubMed ID: 30668379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis and Investigation of New Diphenyl Substituted Pyridazinone Derivatives as Both Cholinesterase and Aβ-Aggregation Inhibitors.
    Kilic B; Erdogan M; Gulcan HO; Aksakal F; Oruklu N; Bagriacik EU; Dogruer DS
    Med Chem; 2019; 15(1):59-76. PubMed ID: 29792155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Potent and Selective Acetylcholinesterase/Butyrylcholinesterase Inhibitors by Virtual Screening.
    Xu T; Li S; Li AJ; Zhao J; Sakamuru S; Huang W; Xia M; Huang R
    J Chem Inf Model; 2023 Apr; 63(8):2321-2330. PubMed ID: 37011147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of New Chromenone Derivatives as Cholinesterase Inhibitors and Molecular Docking Studies.
    Iqbal J; Abbasi MSA; Zaib S; Afridi S; Furtmann N; Bajorath J; Langer P
    Med Chem; 2018; 14(8):809-817. PubMed ID: 29473519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationship investigation of coumarin-chalcone hybrids with diverse side-chains as acetylcholinesterase and butyrylcholinesterase inhibitors.
    Kang L; Gao XH; Liu HR; Men X; Wu HN; Cui PW; Oldfield E; Yan JY
    Mol Divers; 2018 Nov; 22(4):893-906. PubMed ID: 29934672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deciphering the Interactions of Bioactive Compounds in Selected Traditional Medicinal Plants against Alzheimer's Diseases via Pharmacophore Modeling, Auto-QSAR, and Molecular Docking Approaches.
    Ojo OA; Ojo AB; Okolie C; Nwakama MC; Iyobhebhe M; Evbuomwan IO; Nwonuma CO; Maimako RF; Adegboyega AE; Taiwo OA; Alsharif KF; Batiha GE
    Molecules; 2021 Apr; 26(7):. PubMed ID: 33915968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential acetylcholinesterase inhibitors to treat Alzheimer's disease.
    Saud A; Krishnaraju V; Taha A; Kalpana K; Malarkodi V; Durgaramani S; Vinoth Prabhu V; Saleh FA; Ezhilarasan S
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(6):2522-2537. PubMed ID: 38567612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinoxaline derivatives: novel and selective butyrylcholinesterase inhibitors.
    Zeb A; Hameed A; Khan L; Khan I; Dalvandi K; Choudhary MI; Basha FZ
    Med Chem; 2014; 10(7):724-9. PubMed ID: 24875826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer's Disease Treatment.
    Ali B; Jamal QM; Shams S; Al-Wabel NA; Siddiqui MU; Alzohairy MA; Al Karaawi MA; Kesari KK; Mushtaq G; Kamal MA
    CNS Neurol Disord Drug Targets; 2016; 15(5):624-8. PubMed ID: 26996169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Selective Butyrylcholinesterase (BChE) Inhibitors through a Combination of Computational Studies and Biological Evaluations.
    Zhou Y; Lu X; Yang H; Chen Y; Wang F; Li J; Tang Z; Cheng X; Yang Y; Xu L; Xia Q
    Molecules; 2019 Nov; 24(23):. PubMed ID: 31757047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.